The Most Human Way to Heal


Healing Vision. Restoring Life.

Early intervention is critical in eye care. Prokera® corneal bandages are designed for treating damaged corneas by creating an environment for regenerative healing.

A Vision of Modern Healing

They are easy-to-use and can be inserted in the office by a trained eye care professional. Because Prokera contains cryopreserved amniotic membrane tissue to promote healing, it excels at restoring a normal and healthy epithelium while minimizing the risk of scar tissue formation. Early intervention with Prokera supports restoration of the cornea’s own healing capabilities, reducing inflammation, improving corneal health, and optimizing long-term outcomes.1-7

Integration Made Easy

Prokera can be easily incorporated into any eye care practice to optimize outcomes.

  • Can be easily placed during a regular office visit or used with surgical interventions
  • May reduce the need for additional patient visits with slow or poor healing
  • Medical device classification ensures high reimbursement
  • Average Medicare reimbursement: $1,458
  • Minimizes a patient’s cost-burden of treatment
  • Easy-to-use packaging
  • Conveniently stored in any on-site refrigerator or freezer

Download Prokera Product Information

To learn more about Prokera, fill out the details below:
By clicking the button below, I agree to receive marketing communications from BioTissue I am aware that I can unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

Desai NR. A comparison of cryopreserved amniotic membrane and bandage contact lens in their ability to provide high-quality healing after superficial keractectomy. Rev Ophthalmol. September 2014:1-6.
John T, Tighe S, Sheha H, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017:6404918 (Epub)
McDonald MB, Sheha H, Tighe S, et al. Treatment outcomes in the Dry Eye Amniotic Membrane (DREAM) study. Clin Ophthalmol. 2018;12:677-681.
Pachigolla G, Prasher P, Di Pascuale MA, et al. Evaluation of the role of PROKERA in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35(4):172-175.
Cheng AM, Zhao D, Chen R, et al. Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf. 2016;14(1):56-63.
Morkin MI, Hamrah P. Efficacy of self-retained cryopreserved amniotic-membrane for treatment of neuropathic corneal pain. Ocul Surf. 2018;16(1):132-138.
Tseng SC. HC-HA/PTX3 purified from amniotic membrane as novel regenerative matrix: Insight into relationship between inflammation and regeneration. Invest Ophthalmol Vis Sci. 2016;57(5):1-8.